Growth Hormone Test Explained: Normal Range, Stimulation Test, Deficiency & Report Reading (India 2026) | ग्रोथ हार्मोन टेस्ट गाइड
Growth Hormone Test Explained: Normal Range, Stimulation Test, Deficiency & Report Reading (India 2026)
ग्रोथ हार्मोन टेस्ट गाइड: नॉर्मल रेंज, Stimulation Test, GH Deficiency, Acromegaly और Report Reading — पूरी जानकारी
Your child is significantly shorter than their peers and the paediatrician has ordered a Growth Hormone (GH) test and IGF-1. Or you are an adult with fatigue, reduced muscle mass, and central obesity — and your endocrinologist has ordered a Growth Hormone Stimulation Test. Growth hormone testing is one of the most complex endocrine investigations — a single random GH level is almost meaningless because GH is secreted in pulses and is undetectable between pulses. Understanding which test to order, how it is performed, and how to interpret the result is critical. This guide explains the complete picture — from random GH to IGF-1 to the gold-standard stimulation and suppression tests — in plain language for Indian patients and families.
If your child is also having a Thyroid Profile (TSH) or Blood Sugar tested alongside, see those guides. For reading lab reports generally, see our beginner's guide to blood test reports.
Growth Hormone testing complex है — random GH level almost meaningless (GH pulses में secreted, बीच में undetectable)। Which test order करें, कैसे perform हो, और result interpret करें — यह guide complete picture देती है। Table of Contents / विषय सूची
- What Is Growth Hormone? / ग्रोथ हार्मोन क्या है?
- GH Tests — Which Test to Order & When
- Normal Range — GH, IGF-1, and Stimulation Test
- Growth Hormone Deficiency — Causes, Symptoms & Diagnosis
- Excess GH — Acromegaly & Gigantism
- Growth Hormone Stimulation Test — Complete Guide
- Test Preparation Checklist
- Frequently Asked Questions / FAQ
What Is Growth Hormone? / ग्रोथ हार्मोन क्या है?
Growth Hormone (GH) — also called Somatotropin — is a 191-amino acid protein hormone produced by the somatotroph cells of the anterior pituitary gland (a pea-sized gland at the base of the brain). GH secretion is controlled by two hypothalamic hormones: GHRH (Growth Hormone Releasing Hormone — stimulates GH release) and Somatostatin (inhibits GH release). GH is secreted in pulses — approximately 6–12 pulses per 24 hours — with the largest pulse occurring during Stage 3–4 deep sleep (approximately 60–90 minutes after falling asleep). Between pulses, serum GH is essentially undetectable even in healthy individuals. This pulsatile nature makes a single random GH blood test almost clinically meaningless.
GH = 191-amino acid protein hormone, anterior pituitary gland के somatotroph cells से। GHRH stimulates, Somatostatin inhibits। 6–12 pulses/24 hours — largest pulse: deep sleep में। Pulses के बीच: GH undetectable, even in healthy people। इसीलिए random GH test = meaningless।- Step 1 — Pituitary releases GH: GHRH from hypothalamus → pituitary releases GH pulses (largest during sleep, also during exercise, stress, fasting, and puberty). GH half-life in blood: 20–30 minutes.
- Step 2 — GH travels to the liver: GH binds to GH receptors in the liver → liver produces IGF-1 (Insulin-like Growth Factor 1, also called Somatomedin C). This is GH's primary action site for growth promotion.
- Step 3 — IGF-1 acts on tissues: IGF-1 circulates in blood bound to IGFBP-3 (binding protein — stabilises IGF-1 and extends its half-life to 12–15 hours). IGF-1 directly stimulates: bone growth plates (linear height growth); muscle protein synthesis; organ growth (liver, kidney); fat metabolism (lipolysis).
- Step 4 — Negative feedback: Rising IGF-1 → feeds back to suppress GHRH and stimulate somatostatin → reduces GH secretion. This elegant feedback loop maintains stable IGF-1 levels despite fluctuating GH pulses.
- Clinical implication: Because IGF-1 is stable throughout the day (unlike pulsatile GH), measuring serum IGF-1 is a far better screening test for chronic GH excess or deficiency than a random GH measurement.
GH Tests — Which Test to Order & When
| Test | What It Measures | When to Order | Limitation |
|---|---|---|---|
| Random Serum GH Basal GH |
GH level at one point in time | Almost never useful alone. May be ordered as part of acromegaly screening (very high random GH >10 ng/mL = suspicious for acromegaly). Very high GH in a child with rapid growth = gigantism screen. | Unreliable for GHD diagnosis — GH is undetectable between pulses in normal people. A low random GH does NOT mean deficiency. |
| Serum IGF-1 Somatomedin C — BEST SCREENING TEST |
Stable proxy for 24-hour GH secretion | First-line screening for: suspected GH deficiency (short stature child, adult GHD symptoms); suspected GH excess (acromegaly, gigantism); monitoring GH therapy; monitoring acromegaly treatment | IGF-1 is affected by nutritional status (low in malnutrition, anorexia), hypothyroidism, liver disease, and diabetes. Must interpret with age-appropriate reference range. |
| GH Stimulation Test (GHST) Gold Standard for GHD |
Peak GH response to a pharmacological stimulus | Confirm GH deficiency when IGF-1 is low or borderline; evaluation of short stature in children; suspected adult GHD after pituitary surgery or radiation; before starting GH therapy | Requires 2–3 hour supervised procedure with IV access; insulin-induced hypoglycaemia has risks (seizure, severe hypoglycaemia); must be done under specialist supervision |
| GH Suppression Test (OGTT-GH) Gold Standard for Acromegaly |
Failure of GH to suppress after glucose load = excess GH | Confirm acromegaly diagnosis; post-treatment monitoring of acromegaly | Requires oral glucose load (75g) and serial GH measurements over 2 hours. GH should suppress to below 1 ng/mL in normal; failure to suppress = acromegaly. |
| IGFBP-3 IGF-1 Binding Protein 3 |
Carrier protein for IGF-1 — reflects GH status | Paediatric GHD screening (especially in younger children where IGF-1 reference ranges overlap); complement to IGF-1 | Less commonly available in Indian labs; ordered alongside IGF-1 for comprehensive paediatric assessment |
Normal Range — GH, IGF-1, and Stimulation Test
*IGF-1 reference ranges are strongly age- and gender-dependent — always use your lab's specific age-appropriate reference range. The values below are illustrative. Units: ng/mL for GH and IGF-1 (= µg/L). Some labs report GH in mIU/L — 1 ng/mL ≈ 2.6–3.0 mIU/L depending on the standard used.
| Test | Normal / Adequate | Borderline / Concerning | Deficiency / Abnormal |
|---|---|---|---|
| Random Serum GH | Can be undetectable (0–0.5 ng/mL) between pulses — normal in healthy people | Not useful for deficiency assessment regardless of value | Only meaningful if very high (acromegaly screen): >10 ng/mL random = suspicious for acromegaly |
| IGF-1 (age-adjusted) Typical illustrative ranges |
Within age-specific reference range (lab-dependent): • Children 5–10 yr: ~50–300 ng/mL • Puberty: ~200–700 ng/mL • Adults 20–30 yr: ~100–350 ng/mL • Adults 60+ yr: ~50–200 ng/mL |
Below lower limit of age-specific range — warrants stimulation test | Very low IGF-1 (below −2 SD for age) = highly suggestive of GHD — confirms the need for stimulation test |
| GH Stimulation Test Peak (after insulin or glucagon) |
Peak GH >10 ng/mL = Normal pituitary GH response | Peak GH 5–10 ng/mL = Partial GHD (India: some use >7 for children) | Peak GH <5 ng/mL = Severe GHD confirmed |
| GH Suppression Test (after 75g oral glucose) |
GH suppresses to <1 ng/mL (some labs: <0.4 ng/mL with sensitive assay) | GH 1–2 ng/mL — equivocal | GH fails to suppress below 1 ng/mL = Acromegaly confirmed |
- IGF-1 reference ranges must be age- and gender-specific: A child in puberty has IGF-1 levels 3–4× higher than a pre-pubertal child and a senior adult. Using adult reference ranges for children is a common and critical error — always check the age band on your specific lab report.
- Nutritional status significantly affects IGF-1: Malnutrition and undernutrition (still common in India) suppress IGF-1 even when GH secretion is normal. A malnourished short child may have low IGF-1 not from GHD but from protein-calorie deficiency — the GH resistance of malnutrition. Nutritional assessment is always needed alongside IGF-1 interpretation.
- The stimulation test threshold controversy: Classic studies used a GH cut-off of 10 ng/mL. Some Indian paediatric endocrinologists use a cut-off of 7 ng/mL for children, as assay platforms vary. Always confirm the cut-off used with your specific endocrinologist and lab.
Growth Hormone Deficiency — Causes, Symptoms & Diagnosis
The most important application of GH testing in India is evaluation of short stature in children — but it is critical to understand that GH deficiency is responsible for only 1–3% of all short stature. The vast majority of short Indian children are short due to: familial short stature (parents are short), constitutional delay of growth and puberty (late bloomers — most common cause), nutritional deficiency (protein, Vitamin D, calories — extremely common in India), hypothyroidism, coeliac disease, or psychosocial deprivation. Before ordering GH testing: assess: familial height potential (mid-parental height), growth velocity (is the child growing at a normal rate — just shorter?), bone age (X-ray of left hand — delayed bone age suggests constitutional delay), nutritional status, TSH, CBC, and kidney function. GH testing is indicated only when growth velocity is truly below normal for age and these other causes are excluded.
GH deficiency can be congenital or acquired:
- Idiopathic GHD — no identifiable cause; most common in children (~75%)
- Congenital pituitary anomalies — pituitary hypoplasia, ectopic posterior pituitary, septo-optic dysplasia (genetic)
- Craniopharyngioma — the most common pituitary region tumour in Indian children; GHD is a frequent presenting feature and complication of surgery
- Cranial irradiation — radiation therapy to the brain (for brain tumours, leukaemia) damages GH-secreting cells; GHD appears months to years post-radiation
- Traumatic brain injury — head trauma; pituitary injury
- Infiltrative diseases — sarcoidosis, histiocytosis
- Infection — tuberculous meningitis (TB meningitis is important in India) can cause pituitary damage
GHD is not only a childhood condition — adults can develop GHD from pituitary tumours, pituitary surgery, cranial radiation, or traumatic brain injury. Adult GHD is frequently overlooked in India because its symptoms are non-specific and overlap with many common conditions. Symptoms of adult GHD:
- Central (abdominal) obesity with reduced lean body mass
- Fatigue, reduced energy, poor exercise capacity
- Reduced bone mineral density (osteoporosis risk)
- Dyslipidaemia (high LDL, low HDL — cardiovascular risk)
- Impaired cognitive function, depression, poor quality of life
- Thin, dry skin; reduced sweating
Recombinant human GH (somatropin) therapy is approved in India for:
- GH deficiency in children (confirmed by stimulation test) — daily subcutaneous injection; started before growth plates close; height gain of 5–10 cm additional expected over 2–5 years
- Turner syndrome — even without GHD (GH in pharmacological doses improves final height)
- Prader-Willi syndrome
- Small for gestational age (SGA) children who have not caught up by age 4
- Idiopathic short stature — controversial; approved in some countries; requires detailed discussion
- Adult GHD (confirmed) — improves body composition, bone density, lipid profile, and quality of life
Excess GH — Acromegaly & Gigantism
Acromegaly is a rare condition caused by a GH-secreting pituitary adenoma (tumour) producing continuous excess GH in adults (after growth plates have closed). Because bones cannot grow longer after puberty, the excess GH causes thickening and enlargement of existing bones and soft tissues. Classic features: enlarged hands and feet (rings no longer fit, shoe size increases); coarsening facial features (prominent jaw — prognathism, enlarged nose, thickened lips, prominent brow ridge); enlarged tongue (macroglossia); widely spaced teeth; excessive sweating and greasy skin; joint pain (arthropathy from bone enlargement); carpal tunnel syndrome; sleep apnoea (tongue and airway enlargement); hypertension; diabetes or glucose intolerance (GH opposes insulin). IGF-1 is markedly elevated. Diagnosis confirmed by GH suppression test (oral glucose — GH fails to suppress below 1 ng/mL). MRI pituitary essential.
Gigantism occurs when GH excess develops in childhood before growth plates close — the excess GH drives excessive linear height growth. Children with gigantism grow at an abnormally rapid rate — often above the 99th percentile height for age — with accelerated skeletal maturation. The cause is usually a pituitary GH-secreting adenoma (same as acromegaly in adults) or — rarely — GH-releasing hormone excess from a hypothalamic tumour. Clinical features in addition to excessive height: delayed puberty, visual field defects (optic chiasm compression by pituitary tumour — causes bitemporal hemianopia), headache. Investigation: very high IGF-1; random GH often elevated; pituitary MRI mandatory. Treatment: transsphenoidal pituitary surgery (first-line); somatostatin analogues (octreotide, lanreotide — medical treatment if surgery incomplete or declined); radiotherapy (slow-acting).
Growth Hormone Stimulation Test — Complete Guide
The GH Stimulation Test (GHST) is the gold standard for diagnosing Growth Hormone Deficiency. It works by challenging the pituitary with a pharmacological stimulus that should provoke maximal GH release — then measuring whether the pituitary responds adequately. Two main protocols are used in India:
The gold standard GH stimulation test — particularly for adult GHD. Mechanism: IV insulin injection → blood glucose falls (target: below 40 mg/dL) → hypoglycaemia is a powerful GH stimulus → pituitary releases maximal GH. Blood samples for GH drawn at: 0, 30, 45, 60, 90, 120 minutes. Simultaneously checks cortisol response (also stimulated by hypoglycaemia — can diagnose adrenal insufficiency simultaneously). GH peak above 10 ng/mL = normal. ITT must NOT be done in: patients with ischaemic heart disease, seizure history, or severe hypopituitarism (adrenal insufficiency must be ruled out before causing hypoglycaemia). ITT requires physician presence throughout, IV access, glucose available for immediate injection if hypoglycaemia is severe. The only centre that should perform ITT: endocrinology departments of tertiary hospitals in India.
Glucagon injection (IM) is used as an alternative to insulin where ITT is contraindicated or unavailable. Glucagon stimulates GH release through hypoglycaemia-independent mechanisms. Blood samples for GH drawn at: 0, 90, 120, 150, 180 minutes. Advantages: safer than ITT (no severe hypoglycaemia risk), can be done in outpatient setting, suitable for children. Disadvantages: less reliable in obese patients (obesity blunts GH response to glucagon), longer test duration (3 hours vs 2 hours for ITT). GH peak above 10 ng/mL = normal. Commonly used in Indian paediatric endocrinology departments for children's GH stimulation testing. Other less commonly used stimulants in India: L-DOPA (oral), clonidine (oral — particularly for children), arginine (IV).
The GH stimulation test is only valid if certain conditions are met beforehand — false-negative results (GH fails to peak despite normal pituitary) occur when:
- Hypothyroidism — untreated hypothyroidism blunts GH response. TSH must be normal before testing. Start thyroid replacement first if TSH is elevated, then retest in 4–8 weeks.
- Obesity — obesity suppresses GH response (GH is low in obese individuals even with a normal pituitary). False-positive GHD diagnosis can occur in obese children without true pituitary disease.
- Cortisol deficiency — must be excluded before performing ITT (adrenal crisis risk during hypoglycaemia). Morning cortisol must be checked first.
- Sex steroid priming — in peripubertal children, the pituitary GH response to stimulation is lower. To prevent false-positive GHD diagnosis in late pre-pubertal children: some endocrinologists prime with oestrogen (girls) or testosterone (boys) for 2–3 days before testing.
- Two stimulation tests using different stimulants, on different days, may be required to confirm GHD diagnosis.
- Peak GH >10 ng/mL: Normal pituitary GH secretion — GH deficiency excluded. Do not treat with GH therapy.
- Peak GH 5–10 ng/mL: Partial GH deficiency — borderline. Repeat with a different stimulation agent on another day. Clinical picture, growth velocity, and IGF-1 considered together.
- Peak GH <5 ng/mL: Severe GHD — confirmed on two separate stimulation tests with two different stimulants. Treat with GH therapy.
- Important: The stimulation test assay platform matters — different labs use different immunoassay platforms that give different absolute GH values. Always use the cut-off validated for the assay platform used by your specific laboratory.
- Children re-tested after reaching final adult height: 50–80% of childhood "idiopathic GHD" children re-test as GH-normal in adulthood — suggesting many had constitutional delay rather than true permanent GHD. Adult re-testing before continuing GH therapy into adulthood is standard practice.
Test Preparation Checklist / टेस्ट की तैयारी
GH testing has different preparation requirements depending on which test is being done:
GH testing की तैयारी इस पर निर्भर करती है कि कौन सा test किया जा रहा है।-
For IGF-1 (serum IGF-1 / Somatomedin C): Fast for 8–12 hours before the test. While IGF-1 is relatively stable throughout the day compared to GH, overnight fasting gives the most consistent results. A fatty meal can influence IGF-1 assays in some platforms. Morning fasting collection is standard. No special conditions beyond fasting are needed — IGF-1 can be collected as a simple outpatient blood test at any NABL lab. Collect alongside: TSH (to exclude hypothyroidism as cause of low IGF-1) and a nutritional assessment (total protein, albumin — to exclude malnutrition as cause of low IGF-1).
-
For GH Stimulation Test (GHST): Overnight fast from the previous midnight. No food, milk, or juice until the test is complete. The test requires a minimum 8–10 hour fast because: (1) food intake stimulates insulin secretion which suppresses GH; (2) hyperglycaemia (high blood sugar from food) physiologically suppresses GH; (3) the test drug (insulin or glucagon) requires a fasted state for proper glucose dynamics. Water is permitted. The child or adult should remain at rest and avoid exercise before and during the test (exercise itself stimulates GH release and can confound results).
-
For GH Stimulation Test: Ensure thyroid function is normal before the test. Check TSH at least 4–6 weeks before the stimulation test. If TSH is elevated (hypothyroidism), correct it first with thyroid replacement therapy — then retest TSH to confirm normalisation, then proceed to GH stimulation. Untreated hypothyroidism blunts the GH response to stimulation, causing a falsely low peak GH that incorrectly suggests GHD.
-
For Insulin Tolerance Test (ITT): The test must be performed in a hospital endocrinology unit with a physician present throughout. The ITT deliberately induces symptomatic hypoglycaemia (blood glucose below 40 mg/dL, with sweating, trembling, palpitations, or mild confusion — these symptoms confirm adequate hypoglycaemia was achieved). A physician must be present to confirm symptoms, monitor the patient, and immediately give IV dextrose if hypoglycaemia becomes severe or prolonged. This test should NEVER be attempted at home or at a collection-only diagnostic centre.
-
Stop growth hormone therapy for 4 weeks before re-testing IGF-1 or doing a stimulation test. If your child is already on GH injections and the endocrinologist wants to re-test to confirm the diagnosis or re-assess the need for continued therapy, GH injections must be stopped for at least 4 weeks before testing. Continuing GH therapy right up to the test day will suppress endogenous GH secretion and give artificially high IGF-1 — making interpretation impossible.
-
Disclose all medications before GH testing. Medications that affect GH levels: high-dose corticosteroids (suppress GH secretion), oestrogens (increase GH levels in women on OCP — IGF-1 may appear falsely normal), alpha-agonists like clonidine (used as GH stimulus — stop if taking for other reasons), dopamine agonists (cabergoline — suppress GH in acromegaly), somatostatin analogues (octreotide — suppress GH; must be stopped before stimulation testing). Provide a complete medication list to the endocrinologist before the test.
✅ Book Growth Hormone Test
For initial screening of suspected GH deficiency or excess, book the Growth Hormone Test:
Affiliate link: I may earn a small commission at no extra cost to you. IGF-1 testing is available at government medical college endocrinology departments in India. The Growth Hormone Stimulation Test (GHST) must be performed at a hospital endocrinology unit — NEVER at a home collection centre. A diagnosis of GH deficiency must always be made by a qualified paediatric endocrinologist or adult endocrinologist, never based on a simple random GH or IGF-1 value alone. Never start GH injections without confirmed diagnosis from a stimulation test.
IGF-1 testing सरकारी medical college endocrinology departments में। GH Stimulation Test: hospital endocrinology unit में ही — home collection centre में NEVER। GH injections: confirmed stimulation test diagnosis के बिना शुरू न करें। Tracking Growth & Supporting Nutrition in Children
Two practical tools for families concerned about their child's growth — a height measurement wall chart (for consistent home tracking of growth velocity, which is more important than single height measurements) and a complete paediatric nutritional supplement (addressing nutritional inadequacy — the most common and most fixable cause of poor growth in Indian children). Always consult a paediatric endocrinologist before ordering GH tests. Never start GH therapy without a confirmed stimulation test diagnosis. Good nutrition and adequate sleep are the most important optimisable factors for growth.
Tracking a child's growth velocity (rate of height gain over time) is far more clinically useful than knowing a single height measurement. A child growing at 6 cm/year who is in the 10th percentile is growing normally for their genetic potential; a child growing at only 3 cm/year who is in the 50th percentile has a growth problem that needs investigation. Indian paediatric endocrinologists consider height velocity below 4–5 cm/year during childhood (4–10 years) as a trigger for GH evaluation. This wall-mounted height chart with measurement markings allows parents to accurately record height every 3–6 months in the home setting. Recording date and height consistently over 6–12 months gives the paediatrician or endocrinologist the growth velocity data needed to decide whether GH testing is necessary — without which a clinical decision cannot be properly made. If your child's height velocity is above 5 cm/year, they are growing at a normal rate regardless of their current height percentile.
View on Amazon IndiaAffiliate link — small commission at no extra cost.
In India, where nutritional inadequacy remains common even in middle-class urban families — with many children eating insufficient protein, Vitamin D, zinc, and total calories — nutritional deficiency is the most common correctable cause of poor growth and low IGF-1. IGF-1 is highly sensitive to protein and calorie intake: a malnourished child will have low IGF-1 and impaired growth even if the pituitary is completely normal (this is called "GH resistance from malnutrition" or the "malnutrition-GH insensitivity"). Addressing nutritional deficiency before ordering GH tests is the correct clinical sequence. Pediasure provides a scientifically formulated combination of protein (7.5g per serving), energy, 37 nutrients including Vitamin D, zinc, calcium, and iron — nutrients specifically shown to support normal IGF-1 levels and linear height growth in children. Multiple clinical studies show Pediasure supplementation improves height and weight gain in nutritionally at-risk children. Consult your paediatrician for appropriate dosing and duration. Pediasure is a nutritional supplement, not a growth hormone treatment. It cannot replace GH therapy in confirmed GH deficiency.
View on Amazon IndiaAffiliate link — small commission at no extra cost.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside Growth Hormone testing in the growth and pituitary workup:
Growth Hormone testing के साथ ये जांचें अक्सर करवाई जाती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
No — a random GH of 0.2 ng/mL does not confirm GH deficiency and is, in fact, completely meaningless for this purpose. This is the most important misconception about GH testing. Growth hormone is secreted in pulses — primarily during deep sleep (the first 60–90 minutes of sleep). Between pulses, which can last 2–4 hours, GH is essentially undetectable in the bloodstream — even in people with perfectly normal pituitary function. A random blood draw during such a between-pulse period in a healthy child with a completely normal pituitary will show GH of 0.1–0.5 ng/mL — indistinguishable from true GH deficiency. The only test that can diagnose GH deficiency is the Growth Hormone Stimulation Test (insulin tolerance test or glucagon stimulation test), where the pituitary is deliberately provoked to release maximal GH. A peak GH above 10 ng/mL on this test confirms normal pituitary function. Before ordering a stimulation test: check IGF-1 and IGF-BP3, ensure TSH is normal, assess growth velocity over 6–12 months, and consult a paediatric endocrinologist.
उत्तर: नहीं — Random GH 0.2 ng/mL = meaningless। GH pulses में secreted — between pulses healthy person में भी undetectable। Stimulation test only = GHD confirm/exclude करता है। पहले: IGF-1 + TSH + growth velocity। Paediatric endocrinologist से consult करें।IGF-1 (Insulin-like Growth Factor 1, also called Somatomedin C) is the primary mediator of GH's growth-promoting effects. GH travels from the pituitary to the liver and stimulates the liver to produce IGF-1, which then directly drives bone, muscle, and tissue growth. IGF-1 is far more useful than a random GH measurement for two reasons: (1) Stability — while GH fluctuates dramatically (undetectable between pulses, then rising 10–100× during a pulse), IGF-1 has a half-life of 12–15 hours and remains relatively constant throughout the day. A single morning IGF-1 level accurately reflects the total GH secretion over the previous 24 hours. (2) Negative feedback — because IGF-1 levels are maintained by the total amount of GH secreted over 24 hours, chronic GH deficiency will consistently lower IGF-1. A child with GHD will have consistently low IGF-1 day after day; a child with normal pituitary function will have normal IGF-1 even if the blood draw happens to catch a between-pulse trough. IGF-1 is therefore the recommended first-line screening test for both GH deficiency and GH excess (acromegaly).
उत्तर: IGF-1 = GH का primary mediator। Liver में GH → IGF-1 production। IGF-1 stable (12–15 hr half-life) vs GH pulsatile। Single morning IGF-1 = 24-hour GH secretion reflect करता है। GHD में: consistently low IGF-1। First-line screening test for GHD और acromegaly।The Growth Hormone Stimulation Test (GHST) is a 2–3 hour supervised procedure done at a hospital endocrinology unit — it cannot be done at a diagnostic collection centre. Here is what to expect: (1) Arrive fasting (8–10 hours, no food, water permitted). (2) IV cannula placed in the arm — multiple blood samples are collected through this without repeated needle sticks. (3) Baseline blood sample drawn for GH, glucose, and cortisol. (4) Stimulus administered — either IV insulin (induces controlled hypoglycaemia) or IM glucagon injection. (5) Blood samples drawn at set intervals (every 30 minutes for 2–3 hours) for GH measurement. (6) Symptoms monitored — in the insulin test, symptoms of hypoglycaemia (sweating, trembling, palpitations, mild confusion) should develop around 20–30 minutes; this is necessary and expected, but a physician is present throughout with IV dextrose ready. (7) After the test — meal given immediately after the last sample. The child/adult can go home after eating and recovering, usually 30–60 minutes after the test ends. Results are typically available in 24–48 hours.
उत्तर: Hospital endocrinology unit में 2–3 hour supervised procedure। Fasting + IV cannula + baseline blood → Stimulus (insulin IV या glucagon IM) → Blood samples हर 30 minutes → Insulin test में hypoglycaemia symptoms expected (physician present, IV dextrose ready) → Test के बाद meal → Results 24–48 hours।Almost certainly not — GH deficiency is responsible for only about 1–3% of all cases of short stature. The vast majority of short Indian children are short for one of these common, benign reasons: Familial short stature (both parents are short — the child is appropriately short for their genetic potential); Constitutional delay of growth and puberty (late bloomers — the child is short now but will catch up and reach a normal final adult height, just 1–2 years later than peers; bone age on X-ray is delayed); Nutritional deficiency (inadequate protein, calories, Vitamin D, zinc — extremely common in India even in middle-class families); Hypothyroidism (always check TSH in a short child); Coeliac disease (gluten intolerance — causes malabsorption and growth failure in Indian children, underrecognised). Before any GH testing: measure growth velocity over 6–12 months (a child growing at 5–6 cm/year is growing normally, regardless of current percentile), assess nutritional intake, check TSH, and assess parental heights. GH testing is only appropriate when growth velocity is genuinely below normal AND other common causes have been excluded.
उत्तर: नहीं — GH deficiency केवल 1–3% short stature में। Most common causes: Familial short stature, constitutional delay (late bloomer), nutritional deficiency (India में very common), hypothyroidism, coeliac disease। पहले: 6–12 months growth velocity, TSH, nutrition। GH testing तभी जब growth velocity genuinely low AND other causes excluded।Acromegaly is a condition of GH excess in adults — caused by a GH-secreting tumour (adenoma) in the pituitary gland. Because adults' bone growth plates have already closed, the excess GH causes thickening and enlargement of existing bones and soft tissues rather than increased height. Classic features: enlarged hands and feet (rings and shoes no longer fit), coarsening facial features (prominent jaw/chin, enlarged nose, wide forehead), excessive sweating, joint pain, sleep apnoea, and often diabetes or glucose intolerance. The condition typically takes 8–10 years from symptom onset to diagnosis — many patients are initially misdiagnosed with arthritis or other conditions. Diagnosis: IGF-1 is markedly elevated (above the upper limit for age); confirmed by the GH Suppression Test — after drinking 75g glucose solution, GH should suppress to below 1 ng/mL in normal individuals; in acromegaly, GH fails to suppress. MRI of the pituitary is then done to identify the tumour. Treatment: transsphenoidal surgery (removing the tumour through the nose) is first-line — cure rate 70–80% for small tumours; somatostatin analogues (octreotide, lanreotide injections) for unresectable tumours or post-surgery residual disease.
उत्तर: Acromegaly = adults में GH-secreting pituitary tumour। Enlarged hands/feet, coarse facial features, sweating, joint pain, sleep apnoea, diabetes। Diagnosis: high IGF-1 + GH suppression test fail (GH <1 ng/mL नहीं होता after glucose) + pituitary MRI। Treatment: transsphenoidal surgery (70–80% cure for small tumours); octreotide/lanreotide injections।Yes — and for the vast majority of children with mild height concerns (not confirmed GH deficiency), optimising natural GH secretion through lifestyle is the most important and most evidence-based first intervention. The three most powerful natural GH stimulators are: (1) Deep sleep — approximately 70–80% of daily GH is released during Stage 3–4 NREM deep sleep in the first half of the night. Children who sleep before 9–10 PM get more high-quality deep sleep and proportionally more GH secretion. Screen time before bed (phone, tablet, TV) delays sleep onset and fragments deep sleep — directly reducing GH pulses. For a child with growth concerns: strict sleep hygiene — no screens 1 hour before bed, consistent sleep time before 10 PM, 9–10 hours total sleep. (2) Vigorous exercise — high-intensity aerobic exercise (running, swimming, cycling) and resistance training (bodyweight exercises, sports) produce significant GH pulses. 45–60 minutes of vigorous daily activity in children directly stimulates GH secretion. (3) Protein-adequate nutrition — protein intake of 1.2–1.5 g/kg/day with adequate calories, Vitamin D (above 30 ng/mL), and zinc (found in nuts, meat, eggs, legumes) are all required for normal IGF-1 production and responsiveness. For a child growing at 4–5 cm/year with no other concerning features: address these three pillars aggressively for 6–12 months before considering GH testing.
उत्तर: हाँ। तीन सबसे powerful natural GH stimulators: 1. Deep sleep — 70–80% daily GH = deep sleep में। रात 10 बजे से पहले सोना, screens बंद, 9–10 hours। 2. Vigorous exercise — daily 45–60 min intense activity। 3. Adequate protein (1.2–1.5 g/kg/day) + Vitamin D + zinc। GH testing से पहले इन तीनों को 6–12 months optimize करें।- Growth Hormone Research Society (GRS): GRS Consensus Guidelines for Diagnosis and Treatment of GH Deficiency
- MedlinePlus (NIH): Growth Hormone Tests — Patient Information
- Indian Academy of Pediatrics (IAP): IAP — Growth & Endocrinology Guidelines for Indian Children
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. A diagnosis of Growth Hormone Deficiency must only be made by a qualified paediatric endocrinologist or adult endocrinologist after confirmed abnormal stimulation test results — never based on a random GH level or IGF-1 alone. The Growth Hormone Stimulation Test (especially insulin tolerance test) must be performed under direct physician supervision at a hospital endocrinology unit. GH therapy (injections) is a prescription medication — never self-administer or purchase without a confirmed diagnosis and valid prescription. GH misuse for athletic enhancement or non-medical height increase is illegal and dangerous.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। GHD diagnosis: qualified paediatric endocrinologist से confirmed stimulation test के बाद — random GH या IGF-1 alone से नहीं। Stimulation test: hospital endocrinology unit में physician supervision में। GH injections: confirmed diagnosis + valid prescription के बिना कभी नहीं। Athletic enhancement के लिए GH misuse = illegal और dangerous।
Comments
Post a Comment